Whole Exome Sequencing-XL, Singleton Analysis
Whole Exome Sequencing-XL, Singleton Analysis
Whole Exome Sequencing–XL (WES-XL), Singleton Analysis is a comprehensive, phenotype-driven exome analysis of genomic data from the patient, to help determine the underlying genetic cause of a patient’s unexplained medical condition. Identified sequence variants may be confirmed via Sanger sequencing or copy number variants by qPCR, if needed, based on the specific variant identified. Only SNV analysis is performed for secondary findings. The patient and/or patient’s guardian may choose whether or not to receive information related to secondary findings. If the laboratory does not have clear consent to report secondary findings, this information will not be included in the final report. If a secondary finding is identified, parents may choose to have the finding confirmed at no additional charge.
The standard WES-XL is a trio analysis that includes the proband and both parents. However, a singleton analysis is available when both parents or siblings are unavailable.
Technical Information
Whole Exome Sequencing – XL (WES-XL) detects single nucleotide variants (SNVs) within exonic regions, intronic regions, promoters, and 3’-UTRs. SNVs are only detected in intergenic regions if the variant has been previously reported. WES-XL will detect copy number variants (CNVs). Disease-associated sequence variants in the mitochondrial genome will also be reported. WES-XL will not detect trinucleotide repeat expansions, methylation abnormalities, balanced rearrangements, and some small exonic-level copy number changes. Reanalysis can be ordered as a separate for an additional charge.
Specimen Requirements
Transport Instructions
Associated Tests
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
